Daniel Opheim, MD
Colon & Rectal Surgery · Des Moines, IANPI 1295821569
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (39.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 77.9% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $1,823 and has fallen 86.3% since, to $250 in 2022.
Across 37 payments — averaging $67.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Conmed Corporation$107
- Takeda Pharmaceuticals U.S.A., Inc.$96
- Medtronic$65
- Johnson & Johnson$64
- Axonics, Inc.$59
- plus $164 from 9 others
What the payments were for
- Travel & lodging$69028%
- Food & beverage$81633%
- Education$1,00040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 9 | $1,951 |
| Conmed Corporation | 1 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $96 |
| Medtronic(2 entities) | 4 | $65 |
| Johnson & Johnson | 3 | $64 |
| Axonics, Inc. | 3 | $59 |
| Braintree Laboratories, Inc. | 2 | $25 |
| THD America, Inc. | 2 | $24 |
| Baxter Healthcare | 2 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Covidien LP | 1 | $17 |
| Sanara Medtech Inc. | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,784
- AIRSEAL$107
How this compares
Too few colon & rectal surgery providers in Iowato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 33 | $1,991 |
| Colestipol Hcl | 16 | $573 |
| Neomycin Sulfate | 32 | $148 |
| Metronidazole | 37 | $71 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Des Moines
- Ohmar CoughlinDes Moines$13K
- Alexander MenningDes Moines$8K
- Mayin LinDes Moines$6K
- Michael PageDes Moines$5K
- Molly GrossDes Moines$2K
- Shankar RamanDes Moines$2K
- Soren KraemerDes Moines$468
- Muneera KapadiaIowa City$10K
- Kristina GuytonIowa City$6K
- Jennifer HrabeIowa City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.